Protection of hepatic stimulator substance against chemotherapeutic liver damage induced by cyclophosphamide in mice inoculated with S_(180) cells;

Objective To establish two fatty liver models of rats: high-fatty diet induced nonalcoholic fatty liver (NAFL), high-fatty diet and alcohol induced compound fatty liver(CFL), to investigate their possible mechanism, and to study the effect of hepatic stimulator substance(HSS) on the two fatty liver models and their possible mechanism after the models were made.

Objective To study the therapy effect and possible mechanism of hepatic stimulator substance (HSS) associated Runganling on nonalcoholic fatty liver disease (NAFLD) of rat.

Measurement and clinical significance of B lymphocyte stimulators level in peripheral blood plasma from patients with B cell malignancies;

B lymphocyte stimulators(Blys)is a new member of tumor necrosis factor superfamily,which produces a marked effect through specific binding with three receptors.

Role of recombinate human B lymphocyte stimulator on peripheral B cells in systemic lupus erythematosus patients;

Expression of B lymphocyte stimulator in peripheral blood mononuclear cells in individuals with systemic lupus erythematosus and the role of interferon-γ on it s expression;

AIM: To clone and express soluble B lymphocyte stimulator (sBLyS).

Objective To assay the effect of hepatic stimulator substance (HSS) on the expression of EGFR/DNA of human hepatoma cells.

Clinical research about prevention from oral ulcer induced by chemotherapy by granulomacrocytic colony stimulating factors(GM-CSF);